reference/28141237

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/28141237

Outgoing Links

Predicate	Object
contentType	Journal Article\|Multicenter Study\|Randomized Controlled Trial\|Research Support, Non-U.S. Gov't
endingPage	337
issn	0007-1048 1365-2141
issueIdentifier	3
pageRange	329-337
publicationName	British Journal of Haematology
startingPage	329
bibliographicCitation	Ludwig H, Spicka I, Klener P, Greil R, Adam Z, Gisslinger H, Tarkovács G, Linkesch W, Maniatis A, Morant R, Drach J, Kuhn I, Schuster J, Hinke A. Continuous prednisolone versus conventional prednisolone with VMCP-interferon-alpha2b as first-line chemotherapy in elderly patients with multiple myeloma. Br J Haematol. 2005 Nov;131(3):329–37. doi: 10.1111/j.1365-2141.2005.05779.x. PMID: 16225652.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_404bcaf69bfd1c5bfda3319a8e4deb39 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cde689fe2f578d34cd9e14502a532eb9 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c04f111c8f921d7f4e1ed70d5e9d6fb8 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_af7b6460d1e1480b1abde0299803df9d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1853ff2afae4f81369de45f3988867d2 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-5637-3688 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6795922d4500e8adc2bb1598b4b219cd http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_114e92606447e05660ec37a33ff8605c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c8e36d79a3eb9d3efe4ce6fcf22b923d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c905e8811502773cced621a0ef6d808b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b4322196325e5f00deed6491c67e2109 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_93a30ebf1a787892599fc646dcbc5a8a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a5639fc887c026754274c3063a554110 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e9216b4fe445071aeb92bde3bb2af32c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_48f5cbfbdfaa8f7894799eafad601988
date	2005-10-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://doi.org/10.1111/j.1365-2141.2005.05779.x https://pubmed.ncbi.nlm.nih.gov/16225652
isPartOf	https://portal.issn.org/resource/ISSN/1365-2141 https://portal.issn.org/resource/ISSN/0007-1048 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/1822
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Continuous prednisolone versus conventional prednisolone with VMCP–interferon‐α2b as first‐line chemotherapy in elderly patients with multiple myeloma
discusses	http://id.nlm.nih.gov/mesh/M0009322 http://id.nlm.nih.gov/mesh/M0005485 http://id.nlm.nih.gov/mesh/M0025711 http://id.nlm.nih.gov/mesh/M0018641 http://id.nlm.nih.gov/mesh/M0022676 http://id.nlm.nih.gov/mesh/M0017460 http://id.nlm.nih.gov/mesh/M0017465 http://id.nlm.nih.gov/mesh/M0552528 http://id.nlm.nih.gov/mesh/M0013330
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D009101Q000188 http://id.nlm.nih.gov/mesh/D000971Q000627 http://id.nlm.nih.gov/mesh/D005938Q000008 http://id.nlm.nih.gov/mesh/D011239Q000008
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D003520Q000008 http://id.nlm.nih.gov/mesh/D000369 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D000077190 http://id.nlm.nih.gov/mesh/D000971Q000008 http://id.nlm.nih.gov/mesh/D014750Q000008 http://id.nlm.nih.gov/mesh/D009101Q000473 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D009367 http://id.nlm.nih.gov/mesh/D008558Q000008 http://id.nlm.nih.gov/mesh/D004334 http://id.nlm.nih.gov/mesh/D011994 http://id.nlm.nih.gov/mesh/D016898Q000008 http://id.nlm.nih.gov/mesh/D016896 http://id.nlm.nih.gov/mesh/D011241Q000008 http://id.nlm.nih.gov/mesh/D016019 http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D008297
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2907 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID134755071 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_7d6a1edc08997e3d7b61d7a07051efb5 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7521 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5388993 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8593 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_3b4db15610dd7e633a8756b837da2caf http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID62313 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID164145 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID45358158 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8235 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8072 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6324671 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3717450 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5755 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6873 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_850d3dd3f0465864f03b25f855d284d1 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5978 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID460612 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9614 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8530 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71296921

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129717275 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128812924

Total number of triples: 91.